VALENTINI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 3.485
AS - Asia 2.670
EU - Europa 2.295
SA - Sud America 289
AF - Africa 87
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.833
Nazione #
US - Stati Uniti d'America 3.402
CN - Cina 1.417
IE - Irlanda 521
SG - Singapore 509
UA - Ucraina 336
FI - Finlandia 293
HK - Hong Kong 263
DE - Germania 262
RU - Federazione Russa 225
BR - Brasile 208
VN - Vietnam 198
FR - Francia 144
SE - Svezia 144
IT - Italia 125
GB - Regno Unito 121
IN - India 76
ZA - Sudafrica 49
CA - Canada 46
AR - Argentina 32
BE - Belgio 30
ID - Indonesia 29
JP - Giappone 24
MX - Messico 24
NL - Olanda 24
BD - Bangladesh 22
TR - Turchia 22
IQ - Iraq 21
PK - Pakistan 14
ES - Italia 13
PL - Polonia 13
SA - Arabia Saudita 12
CO - Colombia 10
MA - Marocco 10
EC - Ecuador 8
IR - Iran 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
LT - Lituania 6
PE - Perù 6
AT - Austria 5
AU - Australia 5
JO - Giordania 5
LV - Lettonia 5
MY - Malesia 5
BO - Bolivia 4
DZ - Algeria 4
MU - Mauritius 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
SN - Senegal 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
EU - Europa 1
GM - Gambi 1
GY - Guiana 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.833
Città #
Dublin 520
Chandler 505
Jacksonville 372
Beijing 290
Ashburn 270
Nanjing 270
Hong Kong 257
Singapore 248
San Jose 242
Dallas 167
Ann Arbor 152
Boardman 146
Nanchang 131
Helsinki 108
Los Angeles 105
Wilmington 104
New York 86
Lawrence 85
Medford 85
Princeton 85
Shenyang 76
Lauterbourg 72
Hebei 70
Changsha 69
Munich 68
Ho Chi Minh City 62
Jiaxing 62
Tianjin 62
Hangzhou 61
Hanoi 51
Shanghai 50
Johannesburg 43
Buffalo 40
Milan 39
Woodbridge 39
Moscow 36
Brussels 30
Orem 25
São Paulo 25
Verona 25
Tokyo 21
Turku 21
Chennai 17
Denver 17
Redondo Beach 17
Frankfurt am Main 15
Norwalk 15
Atlanta 14
Chicago 14
Dearborn 14
Falls Church 14
Montreal 14
Pavia 14
Boston 13
Toronto 13
London 12
Auburn Hills 11
Da Nang 11
Jinan 11
The Dalles 11
Warsaw 11
Brooklyn 10
Haiphong 10
Mexico City 10
Mumbai 10
Phoenix 10
Piscataway 10
Santa Clara 10
Des Moines 9
Fairfield 9
Seattle 9
Stockholm 9
Tappahannock 9
Amsterdam 8
Buenos Aires 8
Houston 8
Tashkent 8
Ankara 7
Curitiba 7
Kunming 7
Lahore 7
Rio de Janeiro 7
Taizhou 7
Baghdad 6
Columbus 6
Jakarta 6
Manchester 6
Ningbo 6
Nuremberg 6
San Francisco 6
Falkenstein 5
Fuzhou 5
Hải Dương 5
Istanbul 5
Jeddah 5
Kiel 5
Lima 5
Poplar 5
Roubaix 5
Thái Bình 5
Totale 5.814
Nome #
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 156
Absence of interaction between doppel and GFAP, Grb2, PrPC proteins in human tumor astrocytic cells 151
Aberrant Doppel Protein Expression in Human Astrocytic Tumors 148
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 146
Letter to the editor regarding Shibayama et al.: Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase. 142
The prion-like doppel protein is soluble in astrocytic tumor 132
Generation of Mutants of Helicobacter pylori L-Asparaginase 132
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 132
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 132
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 129
Phosphoglycerate Kinase Deficiency: Characterization of the Wild-Type Enzyme and Three Pathological Variants Generated from C.140T>a, C.491A>T and C.959G>a Mutations 128
Expanding targets for a metabolic therapy of cancer: L-asparaginase 128
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 126
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 126
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 125
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli: ligands promoted conformational changes 125
Crystallization and preliminary X-ray analysis of pyruvate kinase type I from Escherichia coli. 124
A simple procedure for the purification of neutral salt soluble type I collagene from skin. 124
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 122
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 121
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 121
Affinity labelling of the catalytic and allosteric ATP binding sites on pyruvate kinase type I from Escherichia coli. 120
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 120
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition 119
Bacterial pyruvate kinases have a shorter N-terminal domain 118
An essential lysine in the substrate-binding of ornithine carbamoyl transferase 117
AMP- and fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. 117
Influence of fibronectine on the fibrillogenesis of type I and type III collagen 117
A comparative study on liver ornithine carbamoyl transferase from a marine mammal Stenella and a elasmobranch Sphyrna zygaena. 116
Biochemical signatures of doppel (Dpl) protein in human glioblastoma to support prediction in tumor malignancy 116
Helicobacter pylori L-asparaginase: from Gene to Diagnostic Tool 116
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 116
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 115
Pyruvate kinase deficiency: Biochemical characterization of two mutations causing inability of the enzyme to properly bind substrates 114
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 114
Recombinant pyruvate kinase type I from Escherichia coli:overproduction and revised C-terminus of the polypeptide 113
Helicobacter pylori: from gene to Diagnostic Tool 113
The allosteric regulation of pyruvate kinase. 113
Two forms of pyruvate kinase in Escherichia coli. A comparison of chemical and molecular properties 109
Molecular cloning and characterisation of Helicobacter pylori L-asparaginase 109
Molecular Insights on Pathogenic Effects of MutationsCausing Phosphoglycerate Kinase Deficiency 109
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 109
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 108
Characterization of a pyrimidine 5'-nucleotidase mutant form (G214R) causing hereditary hemolytic anemia. 108
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia 106
SELECTION OF MICROFUNGI WITH HIGH LIPOLYTIC ACTIVITYAND THEIR LIPASE CHARACTERIZATION 105
Premio Ricercatissimi 2008 104
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. Natures of bonds involved in the allosteric mecchanism. 103
Reactivity of the fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli with pyridoxal 5’-phosphate 101
Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia 99
Investigating the Molecular Bases of the Phosphoglycerate Kinase Deficiency: Characterization ofG158V, R206P, V266M and D285V Pathological Variants. 96
EXPRESSION AND CHARACTERIZATION OF THE BOVINE PRION DOPPEL 95
Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia 95
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5-Nucleotidase Causing Hereditary Hemolytic Anemia. 95
Pyrimidine 5' Nucleotidase Deficiency: Clinical and Molecular Characterization of Two New Italian Patients 95
Aeroplane shaped crystal of a mutant ofHelicobacter pylori L-asparaginase. 94
Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations 91
Purification and molecular properties of the AMP-activated pyruvate kinase from Escherichia coli. 90
Molecular and functional characterization of a lethal variant of pyruvate kinase deficiency 88
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 88
Human erythrocyte pyruvate kinase:characterization of the recombinant enzyme and a mutant form(R510Q))causing nonspherocytic hemolytic anemia. 88
Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography. 87
Red cell pyruvate kinase deficiency: molecular and clinical aspects 87
PYRUVATE KINASE DEFICIENCY: MOLECULAR AND FUNCTIONAL CHARACTERISATION OF A LETHAL VARIANT 87
Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency 87
Molecular Basis of Hemolytic Anemia: First Biochemical Characterization of Wild-Type and N190S Mutant Human Erythrocyte Pyrimidine 5'-Nucleotidase. 87
Functional and structural characterization of ovine ornithine transcarbamoylase 85
Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. 85
The allosteric regulation of pyruvate kinase 83
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene 83
PHOSPHOGLYCERATE KINASE DEFICIENCY: FUNCTIONAL PROPERTIES OF THE L89P, K191DEL, C316R AND A354P PATHOLOGICAL VARIANTS 83
Pyruvate kinase deficiency : The genotype-phenotype association 82
Two new mutations of the P5'N-1 gene found in Italian patients with hereditary hemolytic anemia: the molecular basis of the red cell enzyme disorder. 81
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview 79
L-ASPARAGINASE FROM HELICOBACTER PYLORI 77
Protein Stability, Folding and Misfolding in Human PGK1 Deficiency 77
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 77
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia 76
The interplay between protein stability and folding co-operativity in loss-of-function genetic disease: The case of human PGK1 deficiency. 76
Molecular Cloning and Characterisation of Helicobacter Pylori L-Asparaginase: A Cytotoxic Factor with Potential Biomedical Applications 76
Functional Analysis of Two Mutants of Pyrimidine 5’ Nucleotidase Causing Nonspherocytic Hemolytic Anemia 76
Helicobacter pylori L-asparaginase: A promising chemotherapeutic agent 67
Monitoring Inosine monophosphate dehydrogenase (IMPDH) in kidney transplant recipients 64
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy 57
Protein stability, folding and misfolding in human PGK1 deficiency 31
Totale 8.879
Categoria #
all - tutte 33.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 0 0 0 0 91 86 19
2021/2022450 6 7 9 6 26 17 15 32 32 20 51 229
2022/20231.411 124 122 9 128 157 155 1 64 594 8 32 17
2023/2024516 121 70 6 43 50 141 7 32 0 12 20 14
2024/20251.228 28 97 45 44 32 52 41 73 322 23 179 292
2025/20262.703 234 197 300 370 357 162 502 111 304 166 0 0
Totale 8.879